tiprankstipranks
Trending News
More News >
Sino Biopharmaceutical Ltd (HK:1177)
:1177
Hong Kong Market

Sino Biopharmaceutical (1177) Income Statement

Compare
23 Followers

Sino Biopharmaceutical Income Statement

Last quarter (Q2 2025), Sino Biopharmaceutical's total revenue was ¥8.79B, an increase of 10.71% from the same quarter last year. In Q2, Sino Biopharmaceutical's net income was ¥1.69B. See Sino Biopharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 28.87B¥ 26.20B¥ 26.03B¥ 26.86B¥ 23.65B
Gross Profit
¥ 23.53B¥ 21.21B¥ 21.54B¥ 21.53B¥ 18.46B
Operating Expenses
¥ 17.39B¥ 15.54B¥ 15.95B¥ 17.19B¥ 14.27B
Depreciation and Amortization
¥ 939.85M¥ 1.07B¥ 1.05B¥ 992.56M¥ 1.56B
EBITDA
¥ 6.11B¥ 6.98B¥ 6.69B¥ 19.87B¥ 5.66B
Operating Income
¥ 6.14B¥ 5.79B¥ 5.59B¥ 5.08B¥ 4.19B
Other Income/Expenses
¥ -858.09M¥ -375.81M¥ -370.95M¥ 13.49B¥ 821.34M
Pretax Income
¥ 5.28B¥ 5.41B¥ 5.21B¥ 18.57B¥ 5.01B
Net Income
¥ 3.50B¥ 2.33B¥ 2.54B¥ 14.61B¥ 2.77B
Per Share Metrics
Basic EPS
¥ 0.20¥ 0.08¥ 0.11¥ 0.78¥ 0.15
Diluted EPS
¥ 0.19¥ 0.10¥ 0.12¥ 0.73¥ 0.15
Weighted Average Shares Outstanding
17.24B 23.39B 18.62B 18.77B 18.80B
Weighted Average Shares Outstanding (Diluted)
18.30B 18.53B 19.02B 19.28B 18.80B
Currency in CNY

Sino Biopharmaceutical Earnings and Revenue History